INDO SMC Limited has announced significant changes to its board composition and committee structure following a board meeting held on April 7, 2026. The pharmaceutical manufacturing company appointed a new independent director while reconstituting its key board committees to ensure continued corporate governance standards.

Board Composition Changes

The board approved the appointment of Mr. Arpankumar Patel (DIN: 08792951) as an Additional Director (Non-Executive, Independent) for a period of 5 years with effect from April 7, 2026. The appointment is subject to approval of shareholders to be obtained within the statutory time period as per applicable provisions.

Mr. Arpankumar Patel, aged 39 years, holds an MBA in International Marketing & Finance and a Bachelor of Pharmacy degree. He brings extensive experience in project management, corporate governance and compliance, risk management and internal controls, strategic business planning, financial analysis and oversight, mergers and acquisitions oversight, and stakeholder management.

Director Resignation

Simultaneously, the board noted the resignation of Mr. Chintan Umeshbhai Bhatt (DIN: 09289074) from his position as Director (Non-Executive, Independent) with effect from the closing of business hours on April 6, 2026. Mr. Bhatt cited his inability to devote sufficient time and attention to the affairs of the company as the reason for his resignation.

Committee Reconstitution

Following the board changes, INDO SMC Limited reconstituted its three key committees with effect from April 7, 2026:

Audit Committee:

Nomination and Remuneration Committee:

Stakeholders Relationship Committee:

Regulatory Compliance and Disclosures

The changes were made pursuant to Regulation 30 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, and based on recommendations from the Nomination and Remuneration Committee. The board meeting commenced at 3:00 P.M. and concluded at 3:30 P.M. on April 7, 2026.

Mr. Chintan Bhatt confirmed that there are no material reasons for his resignation other than those mentioned in his resignation letter. Post-resignation, he continues to serve as an Independent Director on the boards of Art Nirman Limited, Sarda Proteins Limited, and Accent Microcell Limited, with one committee chairmanship at Accent Microcell Limited.

Key Regulatory Details

Mr. Arpankumar Patel is not related to any Directors or Key Managerial Personnel of the Company and is not debarred from holding the office of director by virtue of any SEBI order or any other such authority. The company has fulfilled all regulatory disclosure requirements as mandated under SEBI circulars and listing regulations, with comprehensive details provided in accordance with SEBI Circular no. SEBI/HO/CFD/CFD-PoD1/P/CIR/2023/123 dated July 13, 2023.

These board changes reflect INDO SMC Limited's commitment to maintaining robust corporate governance structures while ensuring appropriate board composition and committee effectiveness.